Drug Store News

OCTOBER 4, 2023

Winn-Dixie is kicking off a a community donation program to support neighbors impacted by breast cancer.

111

111

PharmExec

FEBRUARY 8, 2024

OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.

52

52

Drug Topics

OCTOBER 13, 2023

Geriatric screening and assessment have not been widely used, despite international society recommendations for screening older patients with cancer.

184

184

PhRMA

JUNE 15, 2023

I always look forward to the American Society of Clinical Oncology’s Annual Meeting, which took place in Chicago earlier this month. It’s an opportunity for the world’s leading cancer experts to celebrate the latest innovations that are changing the treatment paradigm for patients with this disease.

222

222

PhRMA

JUNE 8, 2023

Last week, I traveled to the American Society of Clinical Oncology’s (ASCO) annual meeting. It’s always an exceptional meeting where the brightest minds in oncology, including researchers, health care providers and industry stakeholders gather to learn about the latest advancements in cancer research and development (R&D).

206

206

Pharmacy Times

FEBRUARY 1, 2024

The late-breaking data at the 2024 American Society of Clinical Oncology Genitourinary Cancers Symposium included the results of KEYNOTE-123 for locally advanced resectable urothelial carcinoma.

136

136

PhRMA

JANUARY 25, 2023

Earlier this month, the American Cancer Society (ACS) released its annual report, Cancer Statistics 2023, finding the overall cancer mortality rate has declined 33% since peaking in 1991, leading to an estimated 3.8 million averted cancer deaths over this period. Here are some key takeaways from the report:

Documentation 254

Documentation 254

Fierce Healthcare

JANUARY 17, 2024

Cancer deaths in the United States are falling, with more than 4 million fewer deaths since 1991. Cancer deaths in the United States are falling, with more than 4 million fewer deaths since 1991.

122

122

STAT

DECEMBER 27, 2023

Reducing or eliminating alcohol consumption reduces the risk of developing oral cavity and esophagus cancers, according to a special report from the International Agency for Research on Cancer. But more data are needed to conclude whether the same is true for several other cancer types, including colorectal, breast, and liver cancer.

145

145

OctariusRx

OCTOBER 2, 2023

October is Breast Cancer Awareness Month and the OctariusRx team is spreading the word and supporting the cause by promoting the annual campaign to increase awareness of this disease. Do You Know Your Risk for Breast Cancer? Breast cancer is much more common in women than in men, but men can develop it, too.

89

89

STAT

MAY 8, 2024

Often overlooked or sidelined by newsmakers and policymakers, these individuals continue to confront a heightened risk of severe illness or death due to their compromised immune systems, while society largely adjusts to life with the virus.

Chemotherapy 113

Chemotherapy Immunization 113

Fierce Pharma

OCTOBER 24, 2023

At this year’s congress of the European Society for Medical Oncology (ESMO), Merck & Co. Across four separate studies, Merck’s PD-1 juggernaut Keytruda—in combination with other cancer meds—charted complete and partial wins in cervical cancer, early breast cancer and stomach cancer.

113

113

Pharmacy Times

JUNE 24, 2022

Breast cancer screening guidelines using mammography vary among guiding bodies, including the American Cancer Society and the American Academy of Family Physicians.

153

153

Fierce Pharma

DECEMBER 5, 2023

As the year comes to a close, shortages of key cancer drugs have no end in sight. | In its letter to congressional leaders, the American Cancer Society Cancer Action Network (ACS CAN) outlined the root causes of drug shortages and offered potential solutions.

98

98

STAT

NOVEMBER 16, 2023

More than a tenth of fecal immunochemical tests, used for routine colorectal cancer screening, contained samples that could not be processed by labs, according to a study published this week in Cancer Epidemiology, Biomarkers and Prevention, a journal of the American Association for Cancer Research.

118

118

STAT

OCTOBER 21, 2023

MADRID — A Roche drug lowered the risk of recurrence or death by 76% versus chemotherapy for patients with a type of early non-small cell lung cancer, according to data from a Phase 3 trial presented Saturday. The results from the Alina trial were presented here at the annual meeting of the European Society for Medical Oncology.

Chemotherapy 139

Chemotherapy 139

Drug Store News

NOVEMBER 7, 2022

The funds will support the organization’s critical need for ongoing research, educational support and supplemental resources to help with early detection and risk reduction.

52

52

Fierce Healthcare

SEPTEMBER 22, 2023

Access to early cancer screenings and intervention can reduce deaths by 45%, according to the American Cancer Society. They delve into strategies for boosting screenings and explore the partnership between Color Health and the American Cancer Society, aimed at making convenient cancer screenings more accessible.

80

80

Pharmacy Times

JUNE 5, 2023

In data presented at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting, amivantamab-vmjw plus lazertinib demonstrated promise as a first-line treatment for patients with advanced EGFR-mutated non-small cell lung cancer.

123

123

Fierce Pharma

FEBRUARY 9, 2024

A year into a dire shortage of essential cancer medicines in the U.S., the American Society of Clinical Oncologists (ASCO) is again pushing Congress to act to end the crisis. |

114

114

Pharmacy Times

JANUARY 29, 2024

Pharmacy Times provides a comprehensive recap of the latest advancements in hematology and breast cancer, shared at the 2023 American Society of Hematology and the San Antonio Breast Cancer Symposium conferences

65

65

STAT

DECEMBER 9, 2023

SAN DIEGO — Researchers on Saturday presented an unusual case of a T cell lymphoma marked with a CAR, the key synthetic protein in CAR-T therapy, here at the American Society of Hematology annual meeting. Continue to STAT+ to read the full story…

FDA 133

FDA 133

STAT

OCTOBER 19, 2023

MADRID — Merck is paying billions of dollars to partner with Daiichi Sankyo on a series of cancer drugs, underscoring the excitement around targeted chemotherapy treatments.     The deal includes a $4 billion upfront payment and an additional $1.5 billion over the next two years.

Chemotherapy 123

Chemotherapy 123

Pharmacy Times

SEPTEMBER 14, 2022

Researchers at the European Society for Medical Oncology Congress presented findings that show osimertinib may clinically reduce the risk of lung cancer recurrence.

123

123

pharmaphorum

AUGUST 1, 2023

In this episode of the pharmaphorum podcast, web editor Nicole Raleigh speaks with André Deschamps, formerly president of Europa Uomo, the voice of men with prostate cancer in Europe. Deschamps is now involved in the Let’s Talk Prostate Cancer (LTPC) Expert Group, as well as the Belgian society, Wij Ook (part of Europa Uomo).

97

97

STAT

APRIL 19, 2023

For many years, there’s been considerable debate about the best age for women to initiate breast cancer screening.The U.S. Preventive Services Task Force recommends that women start getting screenings around age 50, while groups such as the American Cancer Society recommend screenings begin at an earlier age.

136

136

STAT

OCTOBER 24, 2023

MADRID — If you had to pinpoint one subject that stood out at this year’s European Society for Medical Oncology meeting , a massive conference with thousands of people from 140-some countries and 2,500 studies presented, it would be a burgeoning type of cancer treatment called antibody-drug conjugates.

Compounding 130

Compounding 130

OctariusRx

OCTOBER 3, 2022

October is Breast Cancer Awareness Month and the OctariusRx team is spreading the word and supporting the cause by promoting the annual campaign to increase awareness of this disease. Do You Know Your Risk for Breast Cancer? Breast cancer is much more common in women than in men, but men can develop it, too. Take the Quiz.

78

78

STAT

OCTOBER 23, 2023

MADRID — Results presented Monday could expand the use of a Novartis therapy for metastatic prostate cancer, moving it from a treatment used after chemotherapy to one with demonstrated benefits beforehand as well. It’s a field that Novartis has poured investments into, and that is attracting interest from other pharma companies.

Chemotherapy 115

Chemotherapy 115

pharmaphorum

FEBRUARY 2, 2024

The World Health Organization (WHO) has said that the burden of cancer on societies around the world is growing at an alarming rate, with a 77% increase in new cases expected by 2050, along with significant gaps in care.

69

69

Fierce Pharma

OCTOBER 22, 2023

MADRID—Attendees for the European Society for Medical Oncology Congress 2023 arrived in Madrid to torrential downpours Thursday evening, a gloomy atmosphere that did not reflect the overall excitem | ESMO attendees arrived in Madrid to torrential downpours Thursday evening, a gloomy atmosphere that did not reflect the overall excitement of an industry (..)

102

102

STAT

OCTOBER 19, 2023

Europe’s major cancer research conference kicks off in Madrid on Friday, with headline — and potentially practice-changing — readouts from trials in lung, prostate, and other types of cancer. STAT will be reporting from the annual meeting of the European Society for Medical Oncology through Monday.

109

109

STAT

OCTOBER 23, 2023

MADRID — A competition has been brewing between two pharma titans — Johnson & Johnson and AstraZeneca — to gain an edge in the market for targeted lung cancer treatments. A primetime presentation here Monday amounted to the latest salvo.

116

116

STAT

JUNE 1, 2023

Tempus, a company that combines DNA sequencing for cancer with artificial intelligence, said Thursday that it is launching a voice-and-text assistant called Tempus One that will give physicians much easier access to patient data. Continue to STAT+ to read the full story…

115

115

Hospital Pharmacy Europe

DECEMBER 18, 2023

The need for comprehensive management of older adults with cancer by the multidisciplinary team, particularly with support from pharmacy, is increasingly important. To this end, the Society of Geriatric Oncology and the French Society of Oncology Pharmacists have published a position paper to support this collaboration.

Chemotherapy 96

Chemotherapy Hospitals Labelling Communication 96

STAT

OCTOBER 23, 2023

MADRID — Questions about one of AstraZeneca’s key cancer drug candidates — and the dribs and drabs that have come out about its performance — have been dogging the company for months. On Monday, data presented here from a trial of the drug in advanced non-small cell lung cancer provided at least a fuller look.

Chemotherapy 115

Chemotherapy 115

Pharmaceutical Technology

APRIL 3, 2023

Ablaze Pharmaceuticals is set to develop a new GPC3-targeted peptide drug candidate for the treatment of liver cancer in China. Ablaze Pharmaceuticals president and CEO Dr Alex Qiao said: “Liver cancer therapy is a significant unmet medical need in China, and existing treatment options are very limited and ineffective. “An

Hospitals 98

Hospitals 98